[Research progress of cardiovascular disease risk prediction models among patients with chronic kidney disease]

Z W Xi1, J X Mo2, Q P Liu1

  • 1Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China.

Insights

Cardiovascular disease (CVD) risk prediction models for chronic kidney disease (CKD) patients often overestimate risk and show significant variability. More independent validation is needed, especially in developing countries, to improve patient management.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Context:

  • Patients with chronic kidney disease (CKD) face elevated risks of cardiovascular disease (CVD).
  • Accurate CVD risk stratification is crucial for effective management of CKD populations.
  • Existing CVD risk prediction models require careful evaluation within the CKD context.

Purpose:

  • To review and analyze the characteristics and performance of CVD risk prediction models used in CKD populations.
  • To identify variability in outcome events, predictive variables, modeling techniques, and predictive performance.
  • To assess the availability and quality of model validation, particularly in developing nations.

Summary:

  • A review of CVD risk prediction models in CKD populations revealed substantial heterogeneity in study designs, outcome measures, and predictors.
  • Models frequently demonstrated an overestimation of CVD risk in CKD patients.
  • There is a notable scarcity of independently validated models and external validation studies, especially concerning model calibration in developing countries.

Impact:

  • Highlights the need for standardized reporting and rigorous validation of CVD risk prediction models for CKD.
  • Informs the development of more accurate and reliable tools for CVD risk assessment in CKD patients.
  • Aims to improve clinical decision-making and patient outcomes by enhancing the utility of risk prediction models.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346